Skip to main content
Metagenomi, Inc. logo

Metagenomi, Inc. — Investor Relations & Filings

Ticker · MGX ISIN · US59102M1045 US Professional, scientific and technical activities
Filings indexed 124 across all filing types
Latest filing 2025-03-17 Annual Report
Country US United States of America
Listing US MGX

About Metagenomi, Inc.

https://metagenomi.co/

Metagenomi, Inc. is a genetic medicines company that develops curative therapeutics using its proprietary genome editing toolbox. The company's approach is founded on metagenomics, the study of genetic material recovered from natural environments, to discover and engineer novel gene editing systems. Its wholly-owned toolbox is designed to be capable of correcting various types of genetic mutations through site-specific deletion, integration, and correction. Metagenomi leverages high-throughput screening and AI-based cloud computing to expand its portfolio of editing technologies, focusing on disease indications with well-understood biology and clear clinical development pathways.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2024
2025-03-17 English
4
Director's Dealing
2025-03-07 English
4
Director's Dealing
2025-03-07 English
4
Director's Dealing
2025-02-05 English
3
Director's Dealing
2025-01-28 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes the appointment of a new director to the board, details about the director's background, and a mention of an updated investor presentation attached as an exhibit. The primary focus is on management changes (appointment of a director) and a furnished investor presentation. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The document is not a full investor presentation report but a regulatory filing announcing these events. Therefore, the most appropriate classification is 'Board/Management Information (MANG)' because it announces changes in the company's board of directors and senior management.
2025-01-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.